Back to Cetera Investment Advisers Cetera Investment Advisers

NKTRNKTR
6 quarters

Position history for Cetera Investment AdvisersCetera Investment Advisers's holdings in Nektar Therapeutics

Cetera Investment Advisers previously held 0 shares of NKTR (Nektar Therapeutics), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$23,157

Total Shares Change

-24,788

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$25.76
0
2025-Q1
Decreased
11,404
-7.2%
$7,7550.0%$11.10
0
2024-Q4
Decreased
12,284
-2.8%
$11,4240.0%$14.10
0
2024-Q3
Decreased
12,638
-10.9%
$16,4290.0%$17.55
0
2024-Q2
Decreased
14,188
-42.8%
$17,5930.0%$18.60
0
2024-Q1
New
24,788
-
$23,1570.0%$13.95
26

Other major holders of NKTR: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used